Shares of Moderna Inc. MRNA, +0.95% inched 0.95% higher to $177.28 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +0.92% rising 0.92% to 12,070.59 and the Dow Jones Industrial Average DJIA, +0.11% rising 0.11% to 34,128.05. This was the stock’s fifth consecutive day of gains. Moderna Inc. closed $39.97 short of its 52-week high ($217.25), which the company achieved on December 14th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson JNJ, -1.65% fell 1.65% to $159.37 and Pfizer Inc. PFE, -0.91% fell 0.91% to $43.32. Trading volume (2.0 M) remained 3.2 million below its 50-day average volume of 5.2 M.